Ultragenyx Pharma (RARE) PT Lowered to $45 at Citi
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $44.28 --0%
Rating Summary:
20 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 5
Rating Summary:
20 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 5
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $45.00 (from $66.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Ultragenyx Pharma (RARE) PT Raised to $61 at TD Cowen
- CME Group (CME) PT Raised to $206 at JPMorgan
- General Dynamics Corp. (GD) PT Raised to $298 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
